Lindberg A, Nordstoga K, Christophersen B, Savonen R, van Tol A, Olivecrona G
Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
Int J Mol Med. 1998 Mar;1(3):529-38. doi: 10.3892/ijmm.1.3.529.
Severe hypertriglyceridemia was previously observed in mink. Affected animals had no detectable lipoprotein lipase activity, but normal amounts of lipoprotein lipase protein in post-heparin plasma. We have now cloned cDNA for lipoprotein lipase from normal mink and identified a single point mutation in the affected animals which most likely explains the deficiency of active lipase. The mutation is located in exon 6 and results in a Pro214Leu substitution. In heterozygote mink the levels of lipoprotein lipase activity and mass in post-heparin plasma were lower than in normal mink, but could not be used to identify carriers of the mutation. In some tissues (heart, muscle, kidney and lung), lipoprotein lipase activity was decreased to about 50%. In adipose tissue there seemed to be a mechanism to compensate for the mutation, resulting in increased mass and approximately the same activity of lipoprotein lipase as in animals not carrying the mutation. Mink had high lipoprotein lipase activity and mass in kidneys, although the levels of mRNA in kidney were many fold lower than in adipose tissue. Mink had very low levels of cholesteryl ester transfer protein activity in plasma. This may contribute to the high levels of HDL in this animal species.
此前在水貂中观察到严重的高甘油三酯血症。患病动物的脂蛋白脂肪酶活性检测不到,但肝素后血浆中的脂蛋白脂肪酶蛋白量正常。我们现已从正常水貂中克隆出脂蛋白脂肪酶的cDNA,并在患病动物中鉴定出一个单点突变,这很可能解释了活性脂肪酶的缺乏。该突变位于外显子6,导致Pro214Leu替代。在杂合子水貂中,肝素后血浆中脂蛋白脂肪酶的活性和质量水平低于正常水貂,但无法用于识别突变携带者。在一些组织(心脏、肌肉、肾脏和肺)中,脂蛋白脂肪酶活性降低至约50%。在脂肪组织中,似乎有一种机制来补偿这种突变,导致脂蛋白脂肪酶的质量增加,活性与未携带突变的动物大致相同。水貂肾脏中的脂蛋白脂肪酶活性和质量较高,尽管肾脏中的mRNA水平比脂肪组织低很多倍。水貂血浆中的胆固醇酯转移蛋白活性水平非常低。这可能是导致该动物物种中高密度脂蛋白水平较高的原因。